Review





Similar Products

drug treatment  (MedChemExpress)
95
MedChemExpress drug treatment
Drug Treatment, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhodamine+123/Rhodamine+123/pm42526770-187-1-20
Average 95 stars, based on 1 article reviews
drug treatment - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
rhodamine 123  (Thermo Fisher)
96
Thermo Fisher rhodamine 123
Rhodamine 123, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhodamine+123/Rhodamine+123%2C+99%2B%25%2C+pure/pm42320117-332-7-9
Average 96 stars, based on 1 article reviews
rhodamine 123 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
rhodamine 123  (MedChemExpress)
95
MedChemExpress rhodamine 123
Rhodamine 123, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhodamine+123/Rhodamine+123/pm42285244-49-7-20
Average 95 stars, based on 1 article reviews
rhodamine 123 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
rhodamine 123  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology rhodamine 123
A. Co-Immunofluorescence staining of MRP1 (Green), MYC (Red), along with DAPI nuclear stain (blue) in Normal non-cancerous esophagus (NE) and Gastroesophageal Junction adenocarcinoma TMA. Captured at 20X Magnification. B. Relative quantification of MRP1 fluorescence intensity and MYC fluorescence intensity in Normal esophagus (NE) and EAC tissue sections. C. Co-relation analysis between MRP1 fluorescence intensity and MYC fluorescence intensity from B. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. D. Western blot analysis of C-MYC, MRP1, and β-ACTIN in untreated control and MK-1775-treated <t>OE33,</t> FLO1, and <t>SK-GT4</t> cell lines. E & F. <t>Rhodamine</t> <t>123</t> intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated OE33 cells (F) G. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated OE33 cells * P <0.05, **P<0.01, ***P<0.001. H & I. Rhodamine 123 intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated SK-GT4 cells (F) J. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated SK-GT4 cells *P<0.05, **P<0.01, ***P<0.001.
Rhodamine 123, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhodamine+123/Rhodamine+123/pmc13052523-155-28-30
Average 93 stars, based on 1 article reviews
rhodamine 123 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
drug efflux  (MedChemExpress)
95
MedChemExpress drug efflux
A. Co-Immunofluorescence staining of MRP1 (Green), MYC (Red), along with DAPI nuclear stain (blue) in Normal non-cancerous esophagus (NE) and Gastroesophageal Junction adenocarcinoma TMA. Captured at 20X Magnification. B. Relative quantification of MRP1 fluorescence intensity and MYC fluorescence intensity in Normal esophagus (NE) and EAC tissue sections. C. Co-relation analysis between MRP1 fluorescence intensity and MYC fluorescence intensity from B. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. D. Western blot analysis of C-MYC, MRP1, and β-ACTIN in untreated control and MK-1775-treated <t>OE33,</t> FLO1, and <t>SK-GT4</t> cell lines. E & F. <t>Rhodamine</t> <t>123</t> intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated OE33 cells (F) G. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated OE33 cells * P <0.05, **P<0.01, ***P<0.001. H & I. Rhodamine 123 intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated SK-GT4 cells (F) J. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated SK-GT4 cells *P<0.05, **P<0.01, ***P<0.001.
Drug Efflux, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhodamine+123/Rhodamine+123/pm42134241-108-0-7
Average 95 stars, based on 1 article reviews
drug efflux - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
rhodamine 123 rho123  (Thermo Fisher)
96
Thermo Fisher rhodamine 123 rho123
A. Co-Immunofluorescence staining of MRP1 (Green), MYC (Red), along with DAPI nuclear stain (blue) in Normal non-cancerous esophagus (NE) and Gastroesophageal Junction adenocarcinoma TMA. Captured at 20X Magnification. B. Relative quantification of MRP1 fluorescence intensity and MYC fluorescence intensity in Normal esophagus (NE) and EAC tissue sections. C. Co-relation analysis between MRP1 fluorescence intensity and MYC fluorescence intensity from B. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. D. Western blot analysis of C-MYC, MRP1, and β-ACTIN in untreated control and MK-1775-treated <t>OE33,</t> FLO1, and <t>SK-GT4</t> cell lines. E & F. <t>Rhodamine</t> <t>123</t> intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated OE33 cells (F) G. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated OE33 cells * P <0.05, **P<0.01, ***P<0.001. H & I. Rhodamine 123 intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated SK-GT4 cells (F) J. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated SK-GT4 cells *P<0.05, **P<0.01, ***P<0.001.
Rhodamine 123 Rho123, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhodamine+123/Rhodamine+123%2C+99%2B%25%2C+pure/pm42134511-54-18-24
Average 96 stars, based on 1 article reviews
rhodamine 123 rho123 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


A. Co-Immunofluorescence staining of MRP1 (Green), MYC (Red), along with DAPI nuclear stain (blue) in Normal non-cancerous esophagus (NE) and Gastroesophageal Junction adenocarcinoma TMA. Captured at 20X Magnification. B. Relative quantification of MRP1 fluorescence intensity and MYC fluorescence intensity in Normal esophagus (NE) and EAC tissue sections. C. Co-relation analysis between MRP1 fluorescence intensity and MYC fluorescence intensity from B. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. D. Western blot analysis of C-MYC, MRP1, and β-ACTIN in untreated control and MK-1775-treated OE33, FLO1, and SK-GT4 cell lines. E & F. Rhodamine 123 intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated OE33 cells (F) G. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated OE33 cells * P <0.05, **P<0.01, ***P<0.001. H & I. Rhodamine 123 intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated SK-GT4 cells (F) J. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated SK-GT4 cells *P<0.05, **P<0.01, ***P<0.001.

Journal: Cancer letters

Article Title: WEE1 Stabilizes MYC to Promote Therapeutic Resistance in Esophageal Adenocarcinoma

doi: 10.1016/j.canlet.2026.218418

Figure Lengend Snippet: A. Co-Immunofluorescence staining of MRP1 (Green), MYC (Red), along with DAPI nuclear stain (blue) in Normal non-cancerous esophagus (NE) and Gastroesophageal Junction adenocarcinoma TMA. Captured at 20X Magnification. B. Relative quantification of MRP1 fluorescence intensity and MYC fluorescence intensity in Normal esophagus (NE) and EAC tissue sections. C. Co-relation analysis between MRP1 fluorescence intensity and MYC fluorescence intensity from B. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. D. Western blot analysis of C-MYC, MRP1, and β-ACTIN in untreated control and MK-1775-treated OE33, FLO1, and SK-GT4 cell lines. E & F. Rhodamine 123 intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated OE33 cells (F) G. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated OE33 cells * P <0.05, **P<0.01, ***P<0.001. H & I. Rhodamine 123 intracellular fluorescence intensity during influx (red) and after 4 hours of efflux (blue) in control (E) & MK-1775 treated SK-GT4 cells (F) J. Percentage of intracellular Rhodamine 123 retained after efflux in Control and MK-1775 treated SK-GT4 cells *P<0.05, **P<0.01, ***P<0.001.

Article Snippet: Significance between the control and MK-1775 treated groups was calculated through an unpaired T-test using Graphpad Prism software Flow cytometry was used to determine the accumulation of intracellular Rhodamine 123 (Santa Cruz Biotechnology, Dallas, TX in OE33 and SK-GT4 cell lines.

Techniques: Inhibition, Immunofluorescence, Staining, Quantitative Proteomics, Fluorescence, Western Blot, Control